Key facts
- Organicin Scientific’s last known valuation is $5.0M (Aug 2025).
- It has raised $750K; the latest was Accelerator/Incubator ($100K) in Aug 2025.
- Notable investors include Plug and Play Tech Center, Techstars, Microsoft for Startups, AWS Startups, Groove Capital — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Organicin Scientific
- ·The full record, as it builds
Funding rounds
No funding rounds for Organicin Scientific are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Organicin Scientific
Developer of biological pesticide technology designed to discover bacteriocins that are built into drugs to prevent and treat diseases. The company's product portfolio includes biological pesticides made using antibiotic alternatives such as bacteriocin and it includes genomic sequences, protein sequences and structures, biochemical properties, bacterial behavior, and inhibitory interaction networks, enabling farmers to enhance crop yield, profitability, and environmental stewardship in a safe, sustainable and eco-friendly manner.
- Sector
- Healthcare
- HQ
- Amherst, MA, United States
- Founded
- 2018
- Employees
- 3
- Website
- organicinscientific.com/
- Ownership
- Privately Held (backing)
Organicin Scientific doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Organicin Scientific shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Organicin Scientific in its N-PORT filings yet. We sweep new filings monthly.